Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christine Ring currently holds 122,824 shares of Nurix Therapeutics, Inc. (NRIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christine Ring has been a net seller of NRIX stock. They have purchased $0 and sold $3.6M worth of shares.
Christine Ring's most recent insider trade was on Aug 3, 2026, when they sold 5,787 shares at $0.00 per share.
Christine Ring serves as Executive at Nurix Therapeutics, Inc. (NRIX). They have executed 135 insider transactions totaling $3.6M over their tenure at the company.
Christine Ring holds the position of Executive at Nurix Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Christine Ring has shown a selling trading pattern, with $0 in total purchases and $3.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christine Ring was on Nov 24, 2025, when they sold $641.8K worth of NRIX shares. This transaction involved 37,600 shares at $17.07 per share.
Christine Ring currently owns 122,824 shares of Nurix Therapeutics, Inc. (NRIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christine Ring's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christine Ring has 135 Form 4 filings on record as an insider at Nurix Therapeutics, Inc..
Set alerts for Christine Ring and 40,000+ other insiders.